GGrantIndex
← Leaderboards

Fernanda Laezza

University Of Texas Med Br Galveston

$9,952,566
Attributed
$14,780,701
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY201225
$2.5M$1.9M$1.3M$625K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,498,093 · 10

By mechanism

R01$13,962,278 · 6
P30$717,392 · 1
R21$423,423 · 1
U18$237,000 · 1
R03$158,000 · 1

Top collaborators

Most similar at University Of Texas Med Br Galveston

Same institution · by research overlap

Others in their field

Top investigators on “Neurons

Research focus

NeuronsBrainElectrophysiology (Science)CellsPatch ClampIn VivoPathway InteractionsNucleus AccumbensSynapsesGeneticMolecularBaseFunctional DisorderSliceSignal TransductionBehaviorLinkTherapeutic DevelopmentVoltageResponsePhenotypeProteinsViral VectorComplex

Grant awards (31)

Probing brain circuit and behavior with protein:protein interaction modulators$794,232
R01 · FY2025 · MH · contact PI
Gulf Coast Center for Precision Environmental Health$717,392
P30 · FY2025 · ES
Probing brain circuit and behavior with protein:protein interaction modulators$794,232
R01 · FY2024 · MH · contact PI
Neurotrophin-dependent regulation of voltage-gated sodium channels$591,816
R01 · FY2024 · MH · contact PI
Neurotoxicology of deltamethrin in the developing brain$486,863
R01 · FY2024 · ES · contact PI
Probing brain circuit and behavior with protein:protein interaction modulators$824,232
R01 · FY2023 · MH · contact PI
Neurotrophin-dependent regulation of voltage-gated sodium channels$591,816
R01 · FY2023 · MH · contact PI
Neurotoxicology of deltamethrin in the developing brain$486,863
R01 · FY2023 · ES · contact PI
Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrin$423,423
R21 · FY2023 · ES · contact PI
Neurotrophin-dependent regulation of voltage-gated sodium channels$591,816
R01 · FY2022 · MH · contact PI
Neurotoxicology of deltamethrin in the developing brain$486,863
R01 · FY2022 · ES · contact PI
Retinoic acid signaling: a novel factor for addiction-related behavior$423,344
R01 · FY2022 · DA
Assessing risks for Alzheimer's disease induced by exposure to environmental pesticides$400,000
R01 · FY2022 · ES · contact PI
Neurotrophin-dependent regulation of voltage-gated sodium channels$591,816
R01 · FY2021 · MH · contact PI
Neurotoxicology of deltamethrin in the developing brain$486,863
R01 · FY2021 · ES · contact PI
Retinoic acid signaling: a novel factor for addiction-related behavior$440,782
R01 · FY2021 · DA
Neurotrophin-dependent regulation of voltage-gated sodium channels$622,966
R01 · FY2020 · MH · contact PI
Neurotoxicology of deltamethrin in the developing brain$486,863
R01 · FY2020 · ES · contact PI
Retinoic acid signaling: a novel factor for addiction-related behavior$420,805
R01 · FY2020 · DA
FGF13: a novel druggable target for treating substance abuse disorders$237,000
U18 · FY2020 · DA · contact PI
Retinoic acid signaling: a novel factor for addiction-related behavior$449,142
R01 · FY2019 · DA
Gpr12: a novel factor for addiction and mental health$158,000
R03 · FY2019 · DA
Discovery of Chemical Probes for Psychiatric Disorders and Addiction$562,032
R01 · FY2018 · MH · contact PI
Retinoic acid signaling: a novel factor for addiction-related behavior$464,503
R01 · FY2018 · DA
Discovery of Chemical Probes for Psychiatric Disorders and Addiction$548,917
R01 · FY2017 · MH · contact PI
Discovery of Chemical Probes for Psychiatric Disorders and Addiction$518,312
R01 · FY2016 · MH · contact PI
Validation of FGF14 as a New Molecular Target of GSK3$382,500
R01 · FY2016 · MH · contact PI
Validation of FGF14 as a New Molecular Target of GSK3$382,500
R01 · FY2015 · MH · contact PI
Validation of FGF14 as a New Molecular Target of GSK3$382,500
R01 · FY2014 · MH · contact PI
Validation of FGF14 as a New Molecular Target of GSK3$367,200
R01 · FY2013 · MH · contact PI
Validation of FGF14 as a New Molecular Target of GSK3$382,500
R01 · FY2012 · MH · contact PI